Utility of Inflammatory Markers in Predicting Hepatocellular Carcinoma Survival after Liver Transplantation

Table 2

Tumor Characteristics and correlation with inflammatory markers.

		NLR			dNLR			LMR			PLR
		<5	≥5	P	<3	≥3	P	<3.45	≥3.45	P	<150	≥150	P
N		122	38		135	25		98	62		133	27
AFP >300		6.6%	7.9%	0.78	6.7%	8%	0.81	9.2%	3.2%	0.15	5.3%	14.8%	0.07
Tumor on explant		78.7%	86.8%	0.27	80.7%	80%	0.93	85.7%	72.6%	0.04	78.2%	92.6%	0.08
Histopathologic Stage (%)	T1	37.7%	31.6%	0.85	37.8%	28%	0.82	35.7%	37.1%	0.37	36.8%	33.3%	0.53
	T2	45.1%	52.6%		45.9%	52%		49%	43.5%		45.9%	51.9%
	T3	4.1%	2.6%		3.7%	4%		5.1%	1.6%		3%	7.4%
Histologic Class	Well differentiated	25%	20%	0.09	24.2%	21.7%	0.81	24.7%	22.4%	0.30	24.8%	19.2%	0.22
	Moderate or poorly differentiated	45.7%	65.7%		49.2%	56.5%		53.8%	44.8%		47.2%	65.4%
Microvascular Invasion		13.1%	23.7%	0.12	14.1%	24%	0.21	20.4%	8.1%	0.04	15%	18.5%	0.65

AFP, alpha fetoprotein; dNLR, derived neutrophil lymphocyte ratio; LMR, lymphocyte monocyte ratio; NLR, neutrophil lymphocyte ratio; PLR, platelet lymphocyte ratio.